Sio Capital Management as of March 31, 2023
Portfolio Holdings for Sio Capital Management
Sio Capital Management holds 44 positions in its portfolio as reported in the March 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Centene Corporation (CNC) | 13.5 | $27M | 433k | 63.21 | |
Cigna Corp (CI) | 11.0 | $22M | 87k | 255.53 | |
Bicycle Therapeutics Sponsored Ads (BCYC) | 10.2 | $21M | 967k | 21.27 | |
AmerisourceBergen (COR) | 10.1 | $21M | 128k | 160.11 | |
United Therapeutics Corporation (UTHR) | 8.3 | $17M | 75k | 223.96 | |
Ge Healthcare Technologies Common Stock (GEHC) | 8.0 | $16M | 197k | 82.03 | |
Organon & Co Common Stock (OGN) | 5.5 | $11M | 472k | 23.52 | |
Medtronic SHS (MDT) | 3.3 | $6.8M | 84k | 80.62 | |
Avantor (AVTR) | 3.0 | $6.0M | 283k | 21.14 | |
Adc Therapeutics Sa SHS (ADCT) | 2.1 | $4.2M | 2.2M | 1.95 | |
Viking Therapeutics (VKTX) | 2.1 | $4.2M | 250k | 16.65 | |
Axonics Modulation Technolog (AXNX) | 1.9 | $3.9M | 71k | 54.56 | |
Globus Medical Cl A (GMED) | 1.9 | $3.8M | 68k | 56.64 | |
Relay Therapeutics (RLAY) | 1.9 | $3.8M | 230k | 16.47 | |
Merrimack Pharmaceuticals Com New (MACK) | 1.7 | $3.4M | 273k | 12.29 | |
Revolution Medicines (RVMD) | 1.3 | $2.7M | 126k | 21.66 | |
Eucrates Biomedical Acquisition Corp. Unit 10/23/2027 | 1.3 | $2.6M | 249k | 10.37 | |
Repare Therapeutics Ord (RPTX) | 1.1 | $2.2M | 229k | 9.84 | |
Cti Biopharma | 1.1 | $2.2M | 526k | 4.20 | |
Savara (SVRA) | 0.9 | $1.8M | 949k | 1.95 | |
Pharvaris N V (PHVS) | 0.9 | $1.8M | 228k | 8.05 | |
Heska Corp Com Restrc New | 0.8 | $1.7M | 18k | 97.62 | |
Elevation Oncology (ELEV) | 0.8 | $1.7M | 877k | 1.90 | |
Inogen (INGN) | 0.7 | $1.5M | 122k | 12.48 | |
Nyxoah Sa SHS (NYXH) | 0.7 | $1.4M | 189k | 7.47 | |
Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.7 | $1.3M | 348k | 3.85 | |
Aprea Therapeutics Com New (APRE) | 0.6 | $1.2M | 280k | 4.44 | |
Corbus Pharmaceuticals Holdings Com New (CRBP) | 0.5 | $1.1M | 150k | 7.27 | |
Modular Medical Com New (MODD) | 0.5 | $1000k | 689k | 1.45 | |
Moleculin Biotech | 0.5 | $971k | 1.0M | 0.96 | |
Ideaya Biosciences (IDYA) | 0.5 | $961k | 70k | 13.73 | |
Fusion Pharmaceuticals (FUSN) | 0.5 | $928k | 246k | 3.77 | |
Aeglea Biotherapeutics | 0.4 | $871k | 3.0M | 0.29 | |
Vanda Pharmaceuticals (VNDA) | 0.4 | $841k | 124k | 6.79 | |
Aslan Pharmaceuticals Spon Ads New (ASLN) | 0.4 | $732k | 254k | 2.88 | |
Neovasc | 0.3 | $657k | 23k | 29.15 | |
Sientra (SIENQ) | 0.2 | $393k | 255k | 1.54 | |
Merus N V (MRUS) | 0.1 | $286k | 16k | 18.40 | |
Nextcure (NXTC) | 0.1 | $192k | 130k | 1.48 | |
Vincerx Pharma Com New (VINC) | 0.1 | $106k | 102k | 1.04 | |
Caremax Com Cl A | 0.0 | $82k | 31k | 2.67 | |
Rocket Pharmaceuticals *w Exp 09/02/2026 (RCKTW) | 0.0 | $65k | 400k | 0.16 | |
Humacyte *w Exp 08/27/2026 (HUMAW) | 0.0 | $30k | 50k | 0.60 | |
Caremax *w Exp 06/08/2026 (CMAXW) | 0.0 | $5.7k | 13k | 0.44 |